Back
Cue Biopharma Vs. Cidara Therapeutics Industry Stock Comparison
Sell
16
CUE
Cue Biopharma
Last Price:
1.04
Seasonality Move:
13.31%
Buy
70
CDTX
Cidara Therapeutics
Last Price:
17.60
Seasonality Move:
12.66%
Sell
16
Cue Biopharma (CUE)
is a Sell
Is Cue Biopharma a Buy, Sell or Hold?
- The current Cue Biopharma [CUE] share price is $1.09. The Score for CUE is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- CUE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
70
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
- The current Cidara Therapeutics [CDTX] share price is $15.12. The Score for CDTX is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- CDTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CUE Stock Price Chart
What is Cue Biopharma's stock price today?
-
The Cue Biopharma share price today is $1.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CUE is experiencing slight selling pressure.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $15.12
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing selling pressure, which indicates risk of future bearish movement.
CUE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 39.31 | Sell |
| Chaikin Money Flow: | -136595 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.28 - 1.76) | Sell |
| Bollinger Bands (100): | (0.57 - 1.35) | Buy |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.9 | Buy |
| Relative Strength Index (14 RSI): | 71.48 | Buy |
| Chaikin Money Flow: | -39717 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.79 - 14.33) | Buy |
| Bollinger Bands (100): | (11 - 13.22) | Buy |
CUE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.38 | Sell |
| 20-day SMA: | 1.54 | Sell |
| 50-day SMA: | 1.16 | Sell |
| 200-day SMA: | 1.39 | Sell |
| 8-day EMA: | 1.3 | Sell |
| 20-day EMA: | 1.41 | Sell |
| 50-day EMA: | 1.26 | Sell |
| 200-day EMA: | 1.46 | Sell |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.43 | Buy |
| 20-day SMA: | 13.5 | Buy |
| 50-day SMA: | 12.01 | Buy |
| 200-day SMA: | 13 | Buy |
| 8-day EMA: | 14.56 | Buy |
| 20-day EMA: | 13.61 | Buy |
| 50-day EMA: | 12.66 | Buy |
| 200-day EMA: | 13.26 | Buy |
Cue Biopharma Earnings Growth & CUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.19 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.97 per share, a decrease next quarter of $0.00 per share, a decrease this year of $18.96 per share, and an increase next year of $15.14 per share.
Cue Biopharma Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||